In summary, we found that the menin/JunD/Pbk axis normally acts as a suppressive mechanism that controls pancreatic beta cell proliferation and mass, regulating the development of T2D and response to MI treatment. This evidence concerns the gene JUND and type 2 diabetes mellitus.